Clinical trials
2 active studies led by Samaritan Biologics, of 2 in all
Source: ClinicalTrials.gov, Studies with Samaritan Biologics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Samaritan Biologics in 4 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Samaritan Biologics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Samaritan Biologics, of 2 in all
Source: ClinicalTrials.gov, Studies with Samaritan Biologics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Samaritan Biologics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Samaritan Biologics is in.
Stories on the topics Samaritan Biologics works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
More than half of deaths in low- and middle-income countries come from conditions emergency care could treat…
Read